Organon shareholders approve Sun Pharma's $11.75 billion acquisition, paving the way for it to become a wholly owned subsidiary.
SENSEX 76,059.77
NIFTY 23,767.45
CRUDEOIL 8,673.00
GOLD 143,363.00
+ 542.00
Sun Pharmaceutical Industries Ltd announced shareholder approval for its Organon & Co acquisition. This significant milestone…
To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that…
Sun Pharmaceutical Industries Ltd expects to complete its $11.75 billion acquisition of US-based Organon in the fourth quarter of…
Sun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales…
Sun Pharma receives investment-grade ratings from Moody's and S&P for its $11.75 billion acquisition of Organon & Co.
Rating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun…
